Options
Amivantamab plus lazertinib versus osimertinib as first-line treatment in EGFR-mutated advanced non-small cell lung cancer: MARIPOSA Asian subset
Journal
Lung Cancer
Journal Volume
204
Start Page
108496
ISSN
0169-5002
Date Issued
2025-06
Author(s)
Byoung Chul Cho
Hidetoshi Hayashi
Jong-Seok Lee
Se-Hoon Lee
Pongwut Danchaivijitr
Ying Cheng
Baogang Liu
Adlinda Alip
Hailin Xiong
Soon Hin How
James Chih-Hsin Yang
Hiroshige Yoshioka
Mehmet Ali Nahit Şendur
Kumar Prabhash
Koichi Azuma
Yun-Gyoo Lee
Chien-Chung Lin
Shingo Matsumoto
Patrapim Sunpaweravong
Yichuan Xia
Melissa Martinez
Joshua M. Bauml
Seema Sethi
Shun Lu
SDGs
Publisher
Elsevier BV
Type
journal-article